Endogenous interleukin-18 improves the early antimicrobial host response in severe melioidosis

Infection and Immunity

Volumn 75, Issue 8, 2007, Pages 3739-3746

  Wiersinga, W Joost ^a   Wieland, Catharina W ^a   Van Der Windt, Gerritje J W ^a   De Boer, Anita ^a   Florquin, Sandrine ^a   Dondorp, Arjen ^b   Day, Nicholas P ^b,c   Peacock, Sharon J ^b,c   Van Der Poll, Tom ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b MAHIDOL UNIVERSITY   (Thailand)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 18 BINDING PROTEIN;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; BURKHOLDERIA PSEUDOMALLEI; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INTERFERON PRODUCTION; KIDNEY; KIDNEY FAILURE; KNOCKOUT MOUSE; LIVER; LIVER CELL DAMAGE; LUNG; MALE; MELIOIDOSIS; MONOCYTE; MORTALITY; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SOIL MICROFLORA; SOUTHEAST ASIA; SPLEEN; WILD TYPE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BLOOD; BURKHOLDERIA PSEUDOMALLEI; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; FEMALE; HISTOCYTOCHEMISTRY; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-18; KIDNEY; LIVER; LUNG; MALE; MELIOIDOSIS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MIDDLE AGED; MONOCYTES; RNA, MESSENGER; SPLEEN; SURVIVAL ANALYSIS; THAILAND;

EID: 34547633851     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00080-07     Document Type: Article

References (29)

1. Bernard, G. R., J. L. Vincent, P. F. Laterre, S. P. LaRosa, J. F. Dhainaut, A. Lopez-Rodriguez, J. S. Steingrub, G. E. Garber, J. D. Helterbrand, E. W. Ely, and C. J. Fisher, Jr. 2001. Efficacy and safety of recombinant human activated protein C for severe sepsis. N. Engl. J. Med. 344:699-709.
2. Bohn, E., A. Sing, R. Zumbihl, C. Bielfeldt, H. Okamura, M. Kurimoto, J. Heesemann, and I. B. Autenrieth. 1998. IL-18 (IFN-gamma-inducing factor) regulates early cytokine production in, and promotes resolution of, bacterial infection in mice. J. Immunol. 160:299-307.
3. Cheng, A. C., and B. J. Currie. 2005. Melioidosis: epidemiology, pathophysiology, and management. Clin. Microbiol. Rev. 18:383-416.
4. Currie, B. J. 2003. Melioidosis: an important cause of pneumonia in residents of and travellers returned from endemic regions. Eur. Respir. J. 22:542-550.
5. Dinarello, C. A., and G. Fantuzzi. 2003. Interleukin-18 and host defense against infection. J. Infect. Dis. 187(Suppl. 2):S370-S384.
6. Endo, S., K. Inada, and S. Yamada. 2000. Interleukin 18 (IL-18) levels in patients with sepsis. J. Med. 31:15-20.
7. Gentili, A., E. Iannella, L. Giuntoli, and S. Baroncini. 2006. System for predicting outcome and for clinical evaluation in sepsis and septic shock: could scores and biochemical markers be of greater help in the future? Comment to: Septic shock: current pathogenic concept from a clinical perspective. Med. Sci. Monit. 12:LE11-LE12.
8. Haque, A., A. Easton, D. Smith, A. O'Garra, N. Van Rooijen, G. Lertmemongkolchai, R. W. Titball, and G. J. Bancroft. 2006. Role of T cells in innate and adaptive immunity against murine Burkholderia pseudomallei infection. J. Infect. Dis. 193:370-379.
9. Hochholzer, P., G. B. Lipford, H. Wagner, K. Pfeffer, and K. Heeg. 2000. Role of interleukin-18 (IL-18) during lethal shock: decreased lipopolysaccharide sensitivity but normal superantigen reaction in IL-18-deficient mice. Infect. Immun. 68:3502-3508.
10. Lauw, F. N., J. Branger, S. Florquin, P. Speelman, S. J. van Deventer, S. Akira, and T. van der Poll. 2002. IL-18 improves the early antimicrobial host response to pneumococcal pneumonia. J. Immunol. 168:372-378.
11. Lauw, F. N., A. J. Simpson, J. M. Prins, M. D. Smith, M. Kurimoto, S. J. van Deventer, P. Speelman, W. Chaowagul, N. J. White, and T. van der Poll. 1999. Elevated plasma concentrations of interferon (IFN)-gamma and the IFN-gamma-inducing cytokines interleukin (IL)-18, IL-12, and IL-15 in severe melioidosis. J. Infect. Dis. 180:1878-1885.
12. Levy, M. M., M. P. Fink, J. C. Marshall, E. Abraham, D. Angus, D. Cook, J. Cohen, S. M. Opal, J. L. Vincent, and G. Ramsay. 2003. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit. Care Med. 31:1250-1256.
13. Mastroeni, P., S. Clare, S. Khan, J. A. Harrison, C. E. Hormaeche, H. Okamura, M. Kurimoto, and G. Dougan. 1999. Interleukin 18 contributes to host resistance and gamma interferon production in mice infected with virulent Salmonella typhimurium. Infect. Immun. 67:478-483.
14. Neighbors, M., X. Xu, F. J. Barrat, S. R. Ruuls, T. Churakova, R. Debets, J. F. Bazan, R. A. Kastelein, J. S. Abrams, and A. O'Garra. 2001. A critical role for interleukin 18 in primary and memory effector responses to Listeria monocytogenes that extends beyond its effects on interferon gamma production. J. Exp. Med. 194:343-354.
15. Netea, M. G., G. Fantuzzi, and B. J. Kullberg. 2000. Neutralization of IL-18 reduces neutrophil tissue accumulation and protects mice against lethal E. coli and Salmonella typhimurium endotoxemia. J. Immunol. 164:2644-2649.
16. Novick, D., S. H. Kim, G. Fantuzzi, L. L. Reznikov, C. A. Dinarello, and M. Rubinstein. 1999. Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity 10:127-136.
17. Novick, D., B. Schwartsburd, R. Pinkus, D. Suissa, I. Belzer, Z. Sthoeger, W. F. Keane, Y. Chvatchko, S. H. Kim, G. Fantuzzi, C. A. Dinarello, and M. Rubinstein. 2001. A novel IL-18BP ELISA shows elevated serum IL-18BP in sepsis and extensive decrease of free IL-18. Cytokine 14:334-342.
18. Oberholzer, A., L. Harter, A. Feilner, U. Steckholzer, O. Trentz, and W. Ertel. 2000. Differential effect of caspase inhibition on proinflammatory cytokine release in septic patients. Shock 14:253-257.
19. Puren, A. J., G. Fantuzzi, and C. A. Dinarello. 1999. Gene expression, synthesis, and secretion of interleukin 18 and interleukin 1beta are differentially regulated in human blood mononuclear cells and mouse spleen cells. Proc. Natl. Acad. Sci. USA 96:2256-2261.
20. Remick, D. G., G. E. Bolgos, and J. Siddiqui. 2003. Inflammatory status in sepsis alters efficacy of interleukin-18 binding protein therapy. Crit. Care Med. 31:2096-2101.
21. Sansonetti, P. J., A. Phalipon, J. Arondel, K. Thirumalai, S. Banerjee, S. Akira, K. Takeda, and A. Zychlinsky. 2000. Caspase-1 activation of IL-1beta and IL-18 are essential for Shigella flexneri-induced inflammation. Immunity 12:581-590.
22. Santanirand, P., V. S. Harley, D. A. Dance, B. S. Drasar, and G. J. Bancroft. 1999. Obligatory role of gamma interferon for host survival in a murine model of infection with Burkholderia pseudomallei. Infect. Immun. 67:3593-3600.
23. Schultz, M. J., S. Knapp, S. Florquin, J. Pater, K. Takeda, S. Akira, and T. van der Poll. 2003. Interleukin-18 impairs the pulmonary host response to Pseudomonas aeruginosa. Infect. Immun. 71:1630-1634.
24. Schultz, M. J., A. W. Rijneveld, P. Speelman, S. J. van Deventer, and T. van der Poll. 2001. Endogenous interferon-gamma impairs bacterial clearance from lungs during Pseudomonas aeruginosa pneumonia. Eur. Cytokine Netw. 12:39-44.
25. Spek, C. A., A. Verbon, H. Aberson, J. P. Pribble, C. J. McElgunn, T. Turner, T. Axtelle, J. Schouten, T. Van Der Poll, and P. H. Reitsma. 2003. Treatment with an anti-CD14 monoclonal antibody delays and inhibits lipopolysaccharide-induced gene expression in humans in vivo. J. Clin. Immunol. 23:132-140.
26. Takeda, K., H. Tsutsui, T. Yoshimoto, O. Adachi, N. Yoshida, T. Kishimoto, H. Okamura, K. Nakanishi, and S. Akira. 1998. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 8:383-390.
27. van der Poll, T., and S. J. van Deventer. 1999. Cytokines and anticytokines in the pathogenesis of sepsis. Infect. Dis. Clin. N. Am. 13:413-426, ix.
28. Weijer, S., M. E. Sewnath, A. F. de Vos, S. Florquin, K. van der Sluis, D. J. Gouma, K. Takeda, S. Akira, and T. van der Poll. 2003. Interleukin-18 facilitates the early antimicrobial host response to Escherichia coli peritonitis. Infect. Immun. 71:5488-5497.
29. Wiersinga, W. J., T. van der Poll, N. J. White, N. P. Day, and S. J. Peacock. 2006. Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei. Nat. Rev. Microbiol. 4:272-282.